Webinar: How Combining Wearable and Lab Data Boosts Engagement and Retention

Health metrics change daily. Most health products measure them only a few times a year.

The months in between are where engagement is lost, and where most of what matters actually happens.

👉 Join us as we walk through our whitepaper Between Two Tests: what changes when continuous wearable data is read alongside laboratory results, and what that combination does to engagement and retention.

Initializing form..

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Description

What you’ll learn:

In this session, you will see the findings of our whitepaper Between Two Tests: why the interval between two lab tests is where engagement is lost, what the market has already done about it, and what sustained engagement is worth across three very different business models.

  • Why the interval is where engagement is lost

Understand why the gap between one test and the next is a structural problem rather than a marketing one, and why it shows up whether you sell tests directly, route screening through an insurer, or run a digital therapeutic.

  • Six market moves in twenty months

See the public record of lab companies adding wearables and wearable companies adding lab tests, with the funding round or distribution deal behind each one, and what that convergence means if you are the one being evaluated against them.

  • Which markers gain from continuous data, and which do not

Explore why the gold standards gain least from a continuous layer, which markers one tier below genuinely change when you add it, and how that plays out across three worked clinical cases in metabolic health, cardiovascular health and perimenopause.

  • What retention is actually worth

See the cohort model run on real parameters, including where break-even sits, how far a typical cohort is from crossing it, and why we hand over the formula instead of a headline number.

  • What this means for insurers and digital health services

Understand how the D2C diagnostics case transfers to models where acquisition cost is close to zero and the constraint becomes participation, adherence and reimbursement rather than payback.

This session is live, which means we will have live Q&A, so don’t be shy to bring questions. Can’t make it? Register anyway and we will send you the recording.

Meet the Speakers

Dr. Isam Haddad

Strategy Advisor, Digital Health
Guest author, Between Two Tests
Isam advises startups, institutions and established companies on strategy in digital health and consumer diagnostics. A biotechnologist by training with a PhD in computational biology, he founded Baze Labs, led it to acquisition and was CTO of Aware Health. His work draws on over twelve years in D2C diagnostics.

Friedrich Lämmel

Co-Founder and CEO, Thryve
Co-Author of "Between Two Tests"
Friedrich co-founded Thryve and leads it as CEO. Thryve is Europe's health data infrastructure layer, harmonising continuous data from more than 500 wearables, sensors and health apps into one comparable signal. Insurers and digital health providers across Europe build their products on it.